mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours

Clinical trials indicate efficacy of drugs inhibiting the mammalian target of rapamycin (mTOR) in the treatment of gastroenteropancreatic neuroendocrine tumours (GEP-NET); however, information on detailed expression and activity patterns of mTOR in these tumours is sparse. We investigated the expres...

Full description

Bibliographic Details

Main Authors:	Kasajima, Atsuko (Author) , Pavel, Marianne (Author) , Darb-Esfahani, Silvia (Author) , Noske, Aurelia (Author) , Stenzinger, Albrecht (Author) , Sasano, Hironobu (Author) , Dietel, Manfred (Author) , Denkert, Carsten (Author) , Röcken, Christoph (Author) , Wiedenmann, Bertram (Author) , Weichert, Wilko (Author)
Format:	Article (Journal)
Language:	English
Published:	2011
In:	Endocrine related cancer Year: 2011, Volume: 18, Issue: 1, Pages: 181-192
ISSN:	1479-6821
DOI:	10.1677/ERC-10-0126
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1677/ERC-10-0126 Verlag, lizenzpflichtig, Volltext: https://erc.bioscientifica.com/view/journals/erc/18/1/181.xml
Author Notes:	Atsuko Kasajima, Marianne Pavel, Silvia Darb-Esfahani, Aurelia Noske, Albrecht Stenzinger, Hironobu Sasano, Manfred Dietel, Carsten Denkert, Christoph Röcken, Bertram Wiedenmann and Wilko Weichert